We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Self-Propelling Micro/Nanorobots Provide Precision Treatment of Gastrointestinal Inflammation

By HospiMedica International staff writers
Posted on 24 Feb 2023
Print article
Image: Twin-bioengine self-adaptive micro/nanorobots developed for gastrointestinal inflammation therapy (Photo courtesy of SIAT)
Image: Twin-bioengine self-adaptive micro/nanorobots developed for gastrointestinal inflammation therapy (Photo courtesy of SIAT)

There has been increased focus on the application of self-propelling and -navigating micro/nanorobots for drug delivery and therapy due to their controllable locomotion in difficult-to-reach body tissues. However, developers continue to face challenges in designing self-adaptive micro/nanorobots that can adjust their driving mechanisms across multiple biological barriers to access distant lesions. Now, a research team has developed a twin-bioengine yeast micro/nanorobot (TBY-robot) with self-propelling and self-adaptive capabilities that can autonomously navigate to inflamed sites for providing gastrointestinal inflammation therapy through enzyme-macrophage switching (EMS).

Researchers at the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences (Beijing, China) have built the TBY-robot by asymmetrically immobilizing glucose oxidase and catalase onto the surface of anti-inflammatory nanoparticle-packaged yeast microcapsules. At a homogeneous glucose concentration, the Janus distribution of enzymes can catalyze the decomposition of glucose to generate a local glucose gradient that induces TBY-robot self-propelling motion. In the presence of an enteral glucose gradient, the oral TBY-robots move toward the glucose gradient to penetrate the intestinal mucus barrier and then cross the intestinal epithelial barrier by microfold cell transcytosis.

After in situ switching to the macrophage bioengine in Peyer's patches, the TBY-robots autonomously migrate to inflamed sites of the gastrointestinal tract through chemokine-guided macrophage relay delivery. This twin-bioengine delivery strategy is a sequence-driven process using EMS, with Peyer's patches as transfer stations. This process can precisely transport therapeutics across multiple biological barriers to distant, deep-seated disease sites. The self-adaptive TBY-robots offer a safe and promising strategy for the precision treatment of gastrointestinal inflammation and other inflammatory diseases.

"We found that TBY-robots effectively penetrated the mucus barrier and notably enhanced their intestinal retention using a dual enzyme-driven engine moving toward the enteral glucose gradient," said Prof. CAI Lintao from the SIAT who led the research team. "Encouragingly, TBY-robots increased drug accumulation at the diseased site by approximately 1000-fold, markedly attenuating inflammation and ameliorating disease pathology in mouse models of colitis and gastric ulcers."

Related Links:
Chinese Academy of Sciences 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Pre-Op Planning Solution
Sectra 3D Trauma

Print article

Channels

Surgical Techniques

view channel
Image: The hyperspectral imaging system extracts molecular vibrations of different resins and distinguishes between them with high reproducibility (Photo courtesy of Hiroshi Takemura from Tokyo University of Science)

Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery

Hyperspectral imaging (HSI) is an advanced technique that captures and processes information across a given electromagnetic spectrum. Near-infrared hyperspectral imaging (NIR-HSI) has particularly gained... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more